Evidence map›Paper›PMID 32321815›Full record

ArticleJournal of virology2020

Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection.

Dirk Eggink, Monique Spronken, Roosmarijn van der Woude, Jocynthe Buzink, Frederik Broszeit, Ryan McBride, Hana A Pawestri, Vivi Setiawaty, James C Paulson, Geert-Jan Boons and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Chemoenzymatic Synthesis of Tri-antennary N-Glycans Terminating in Sialyl-LewisChemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Dirk EgginkDepartment of Medical Microbiology, Academic Medical Center, Amsterdam, the Netherlands w.d.eggink@amsterdamumc.nl.
Monique SpronkenDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Roosmarijn van der WoudeDepartment of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Jocynthe BuzinkDepartment of Medical Microbiology, Academic Medical Center, Amsterdam, the Netherlands.
Frederik BroszeitDepartment of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Ryan McBrideDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
Hana A PawestriNational Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia.
Vivi SetiawatyNational Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia.
James C PaulsonDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
Geert-Jan BoonsDepartment of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Ron A M FouchierDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Colin A RussellDepartment of Medical Microbiology, Academic Medical Center, Amsterdam, the Netherlands.
Menno D de JongDepartment of Medical Microbiology, Academic Medical Center, Amsterdam, the Netherlands.
Robert P de VriesDepartment of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Academic Medical Center · NLErasmus MC · NLUtrecht University · NLMinistry of Health · IDScripps Research Institute · USUniversity of Georgia · US

Funding

Influenza virus receptors on human airway epithelial cellsR01AI114730 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI PAULSON, JAMES C · 2015 to 2023
$5.1M
NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI114730
6 · The paper itself

Abstract

Highly pathogenic avian influenza (HPAI) viruses are enzootic in wild birds and poultry and continue to cause human infections with high mortality. To date, more than 850 confirmed human cases of H5N1 virus infection have been reported, of which ∼60% were fatal. Global concern persists that these or similar avian influenza viruses will evolve into viruses that can transmit efficiently between humans, causing a severe influenza pandemic. It was shown previously that a change in receptor specificity is a hallmark for adaptation to humans and evolution toward a transmittable virus. Substantial genetic diversity was detected within the receptor binding site of hemagglutinin of HPAI A/H5N1 viruses, evolved during human infection, as detected by next-generation sequencing. Here, we investigated the functional impact of substitutions that were detected during these human infections. Upon rescue of 21 mutant viruses, most substitutions in the receptor binding site (RBS) resulted in viable virus, but virus replication, entry, and stability were often impeded. None of the tested substitutions individually resulted in a clear switch in receptor preference as measured with modified red blood cells and glycan arrays. Although several combinations of the substitutions can lead to human-type receptor specificity, accumulation of multiple amino acid substitutions within a single hemagglutinin during human infection is rare, thus reducing the risk of virus adaptation to humans.

Indexed as

Adaptation, PhysiologicalAmino Acid SubstitutionAnimalsBinding SitesBiological Variation, PopulationBirdsDogsHemagglutinin Glycoproteins, Influenza VirusHemagglutinins, ViralHumansInfluenza A virusInfluenza A Virus, H5N1 SubtypeInfluenza, HumanInfluenza in BirdsMadin Darby Canine Kidney CellsPoultryHemagglutinin Glycoproteins, Influenza VirusHemagglutinins, ViralReceptors, VirusH5N1hemagglutininhuman adaptationinfluenza virusreceptor specificity

Identifiers

PMID32321815
PMCPMC7307160
OpenAlexW3019092342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.